Back to search
Non-hypovolemic Non-acute Hyponatremia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Non-hypovolemic Non-acute Hyponatremia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Non-hypovolemic Non-acute Hyponatremia trials you may qualify forThis is a randomized, double-blind, multicenter, placebo-controlled (standard therapy + placebo), phase 2 efficacy and safety study of the Tolvaptan tablets in…
This drug has been developed to treat Hyponatremia. The primary purpose of this study is to verify the efficacy and safety of seven-day repeated oral administra…